RNA - Avidity Biosciences  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RNA is currently covered by 7 analysts with an average price target of $69.14. This is a potential upside of $21 (43.62%) from yesterday's end of day stock price of $48.14.

Avidity Biosciences 's activity chart (see below) currently has 8 price targets and 42 ratings on display. The stock rating distribution of RNA is 93.94% BUY and 6.06% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.9% with an average time for these price targets to be met of 358.43 days.

Highest price target for RNA is $46, Lowest price target is $18, average price target is $69.14.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 12-Jun-2024. First documented stock forecast 07-Jul-2020.

Currently out of the existing stock ratings of RNA, 31 are a BUY (93.94%), 2 are a HOLD (6.06%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

45

$-0.12 (-0.27%)

33

1 months 14 days ago

8/8 (100%)

$6.64 (17.31%)

299

Buy

46

$0.88 (1.95%)

35

1 months 14 days ago

12/12 (100%)

$7.64 (19.92%)

228

Buy

18

$-27.12 (-60.11%)

8 months 17 days ago

2/3 (66.67%)

$12.52 (228.47%)

774

Buy

30

$-15.12 (-33.51%)

30

11 months 17 days ago

8/8 (100%)

$20.65 (220.86%)

581

Buy

20

$10.67 (114.36%)

20

1 years 2 months 5 days ago

0/2 (0%)

$7.92 (65.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RNA (Avidity Biosciences ) average time for price targets to be met?

On average it took 358.43 days on average for the stock forecasts to be realized with a an average price target met ratio 61.9

Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on RNA (Avidity Biosciences ) with a proven track record?

YANAN ZHU

Which analyst has the most public recommendations on RNA (Avidity Biosciences )?

Judah Frommer works at MORGAN STANLEY and has 7 price targets and 2 ratings on RNA

Which analyst is the currently most bullish on RNA (Avidity Biosciences )?

Steven Seedhouse with highest potential upside - $25.88

Which analyst is the currently most reserved on RNA (Avidity Biosciences )?

Joseph Schwartz with lowest potential downside - -$27.12

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?